Literature DB >> 25457411

MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker.

Yao Dai, Dongsheng Dai, Jawahar L Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25457411     DOI： 10.1016/j.jacc.2014.03.064

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  MicroRNA-29: A Crucial Player in Fibrotic Disease.

Authors:  Zhenjun Deng; Yongjing He; Xujuan Yang; Hang Shi; Ao Shi; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

2.  MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin.

Authors:  Kristin N Heller; Joshua T Mendell; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  JCI Insight       Date:  2017-05-04

3.  MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13.

Authors:  Yuhong Zhou; Lin Deng; Dandan Zhao; Lanlan Chen; Zhen Yao; Xiaowei Guo; Xue Liu; Lifang Lv; Bing Leng; Wei Xu; Guofen Qiao; Hongli Shan
Journal:  J Cell Mol Med       Date:  2016-01-12       Impact factor: 5.310

Review 4.  Non-ischemic dilated cardiomyopathy and cardiac fibrosis.

Authors:  Bianca Olivia Cojan-Minzat; Alexandru Zlibut; Lucia Agoston-Coldea
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

Review 5.  Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.

Authors:  Celestino Sardu; Michelangela Barbieri; Maria Rosaria Rizzo; Pasquale Paolisso; Giuseppe Paolisso; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.